Los Angeles Capital Management
AGN

Los Angeles Capital Management’s Allergan Inc AGN Stock Holding History

Los Angeles Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,493
Closed -$743K – 1302
2014
Q4 		$743K Hold
3,493
– – 0.01% 725
2014
Q3 		$622K Hold
3,493
– – 0.01% 719
2014
Q2 		$591K Sell
3,493
-181,477
-98% -$28.3M 0.01% 825
2014
Q1 		$23M Buy
184,970
+20,735
+13% +$2.52M 0.25% 121
2013
Q4 		$18.2M Buy
164,235
+5,188
+3% +$496K 0.2% 151
2013
Q3 		$14.4M Buy
159,047
+28,475
+22% +$2.56M 0.18% 168
2013
Q2 		$11M Buy
+130,572
New +$13.5M 0.16% 175

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Los Angeles Capital Management's AGN Position: Q1 2015 in Review

Los Angeles Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,493 shares — an estimated $743K sold.

Los Angeles Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $23M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Los Angeles Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Los Angeles Capital Management sold 3,493 Allergan Inc shares in Q1 2015, an estimated $743K.
  • Los Angeles Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Los Angeles Capital Management's Allergan Inc position peaked at $23M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Los Angeles Capital Management's 13F filing for Q1 2015, filed 6 May 2015.